Facility Agreements in the Biotechnology Industry

31 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
2025 Facility Agreement between Hanmi Pharmaceutical Co., Ltd. and Aptose Biosciences Inc. (with Guarantors)
Facility Agreements
Aptose Biosciences Inc.
Biotechnology
2025
First Amendment to Working Capital Facility Agreement by and among Heron Therapeutics, Inc., Hercules Capital, Inc., and Lenders
Facility Agreements
HERON THERAPEUTICS, INC.
Biotechnology
CA
2025
Facility Agreement between Hanmi Pharmaceutical Co., Ltd. and Aptose Biosciences Inc. dated August 27, 2024
Facility Agreements
Aptose Biosciences Inc.
Biotechnology
NY
2024
Addendum to Scope of Work for Cleanroom 3 Use Between Synlogic Operating Company, Inc. and Azzur Cleanrooms on Demand
Facility Agreements
SYNLOGIC, INC.
Biotechnology
2024
Working Capital Facility Agreement among Heron Therapeutics, Inc., Its Subsidiaries, Hercules Capital, Inc., and Lenders (August 9, 2023)
Facility Agreements
HERON THERAPEUTICS, INC.
Biotechnology
DC
2023
Facility Agreement between China Merchants Bank Co., Ltd. and BeiGene, Ltd.
Facility Agreements
BeiGene, Ltd.
Biotechnology
2023
Second Amendment to Facility License Agreement between NantWorks, LLC and ImmunityBio, Inc.
Facility Agreements
NantKwest, Inc.
Biotechnology
2022
Manufacturing Support Agreement between Arcturus Therapeutics, Inc. and Economic Development Board (Singapore)
Facility Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
CA
2020
First Amendment to Facility License Agreement between NantWorks, LLC and NantKwest, Inc.
Facility Agreements
NantKwest, Inc.
Biotechnology
2020
First Amendment to Secured Convertible Facility Agreement between AgeX Therapeutics Inc. and Juvenescence Limited
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2020
Secured Convertible Facility Agreement among AgeX Therapeutics Inc., Juvenescence Limited, ReCyte Therapeutics Inc., and Reverse Bioengineering, Inc. dated March 30, 2020
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
2020
Amended and Restated Interim Facility Agreement between Curetis GmbH and Crystal GmbH dated March 18, 2020
Facility Agreements
OPGEN INC
Biotechnology
2020
Interim Facility Agreement between Curetis GmbH and Crystal GmbH dated November 12, 2019
Facility Agreements
OPGEN INC
Biotechnology
2019
Amendment No. 1 to Facility Use Agreement between Institute for Systems Biology and Neoleukin
Facility Agreements
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2019
Facility Use Agreement between Institute for Systems Biology and Neoleukin, dated December 4, 2018
Facility Agreements
AQUINOX PHARMACEUTICALS, INC
Biotechnology
WA
2019
Facility License Agreement between NantWorks, LLC and NantKwest, Inc. (2015)
Facility Agreements
NantKwest, Inc.
Biotechnology
DE
2016
Second Amendment to Facility Agreement between Discovery Laboratories, Inc. and Deerfield Lenders
Facility Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
2015
First Amendment to Facility Agreement between Discovery Laboratories, Inc. and Deerfield Lenders (July 9, 2015)
Facility Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
2015
Facility Construction and Commercial Supply Agreement between Lonza Biologics, Inc. and Celladon Corporation (Effective October 31, 2014)
Facility Agreements
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2015
Second Amendment to Facility Agreement among MannKind Corporation and Deerfield Private Design Funds
Facility Agreements
MANNKIND CORP
Biotechnology
NY
2014
First Amendment to Facility Agreement between Infinity Pharmaceuticals, Inc. and Deerfield Lenders
Facility Agreements
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2014
First Amendment to Facility Agreement and Registration Rights Agreement between Cytomedix, Inc. and Deerfield Lenders
Facility Agreements
Nuo Therapeutics, Inc.
Biotechnology
2014
Facility Agreement between Infinity Pharmaceuticals, Inc. and Lenders dated February 24, 2014
Facility Agreements
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2014
Cytomedix, Inc. $35 Million Facility Agreement with Lenders Dated March 31, 2014
Facility Agreements
Nuo Therapeutics, Inc.
Biotechnology
NY
2014
First Amendment to Facility Agreement and Registration Rights Agreement by and among MannKind Corporation and Deerfield Private Design Funds
Facility Agreements
MANNKIND CORP
Biotechnology
NY
2014
Facility Agreement between Discovery Laboratories, Inc. and Lenders dated February 13, 2013
Facility Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
NY
2013
Facility Agreement between Arena Pharmaceuticals, Inc. and Lenders dated June 17, 2009
Facility Agreements
ARENA PHARMACEUTICALS INC
Biotechnology
NY
2009
Facility Agreement between Exelixis, Inc. and Deerfield Private Design Fund, L.P. and Affiliates
Facility Agreements
Exelixis
Biotechnology
NY
2008
Facility Agreement between Exelixis, Inc. and Deerfield Lenders dated June 4, 2008
Facility Agreements
Exelixis
Biotechnology
NY
2008
Amended Credit Facility Agreement between MFC Merchant Bank S.A. and Mymetics Corporation (August 13, 2001)
Facility Agreements
MYMETICS CORP
Biotechnology
2003
Facility Reservation Agreement between Packaging Coordinators, Inc. and Novavax Inc.
Facility Agreements
NOVAVAX INC
Biotechnology
PA
2002